Mangoceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022
Market Capitalization	8	6	-
Market Cap Growth	-72.15%	-	-
Enterprise Value	8	6	-0
PE Ratio	-	-0.67	-
PS Ratio	9.11	8.49	-
PB Ratio	-5.07	8.01	-
P/FCF Ratio	-0.79	-0.89	-
P/OCF Ratio	-0.79	-0.89	-
EV/Sales Ratio	9.31	7.63	-38.81
EV/EBITDA Ratio	-0.56	-0.61	0.17
EV/EBIT Ratio	-0.56	-0.61	0.17
EV/FCF Ratio	-0.81	-0.80	0.25
Debt / Equity Ratio	-0.21	0.17	0.57
Debt / EBITDA Ratio	-0.02	-0.01	-0.18
Debt / FCF Ratio	-0.03	-0.02	-0.25
Quick Ratio	0.03	3.58	2.69
Current Ratio	0.07	3.88	2.67
Asset Turnover	0.54	0.29	0.02
Interest Coverage	-	-	-307.68
Return on Equity (ROE)	-864.40%	-411.70%	-669.00%
Return on Assets (ROA)	-577.80%	-366.40%	-389.50%
Return on Capital (ROIC)	1191.47%	-1020.43%	-205.98%
Earnings Yield	-117.22%	-148.40%	-
FCF Yield	-80.30%	-112.77%	-
Buyback Yield / Dilution	-102.80%	-49.22%	-
Total Shareholder Return	-102.80%	-49.22%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).